WHAT EU MEAN TO THE MHRA! POTENTIAL IMPACT OF ‘BREXIT’ ON PHARMACEUTICAL REGULATION IN THE UK

Author(s)

Macaulay R¹, Attri S², Pandey V², Ahuja A³
¹Parexel Access Consulting, London, UK, ²Paraxel International, Chandigarh, India, ³PAREXEL Access Consulting, Chandigarh, India

Presentation Documents

PHP2--strong-u-macaulay-r-u-sup-1-sup-strong-attri-s-sup-2-sup-pandey-v-sup-2-sup-ahuja-a-sup-3-sup-br-sup-1-sup-parexel-access-consulting-london-uk-sup-2-sup-paraxel-international-chandigarh-india-sup-3-sup-parexel-access-consulting-chandi ...

OBJECTIVES:

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PHP2

Topic

Epidemiology & Public Health, Health Policy & Regulatory, Health Service Delivery & Process of Care, Health Technology Assessment, Patient-Centered Research

Topic Subcategory

Approval & Labeling, Decision & Deliberative Processes, Health Care Research, Patient Behavior and Incentives, Pricing Policy & Schemes, Public Health, Reimbursement & Access Policy

Disease

Multiple Diseases

Explore Related HEOR by Topic

Presentation